MoneyWorks4Me

Anuh Pharma - Quaterly Results

09 Feb 2024 Evaluate
A fair growth of 24.05% in the revenue at Rs. 1721.01 millions was reported in the December 2023 quarter as compared to Rs. 1387.30 millions during year-ago period.The Net Profit of the company vaulted to 105.35% to Rs. 191.12  millions from Rs. 93.07 millions in the previous quarter.OP of the company witnessed a marginal growth to 276.49 millions from 145.42 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1721.01 1387.30 24.05 4831.14 3701.77 30.51 5274.86 4866.46 8.39
Other Income 36.57 21.13 73.07 92.76 50.78 82.67 61.15 51.97 17.66
PBIDT 276.49 145.42 90.13 652.03 421.20 54.80 573.90 520.43 10.27
Interest 1.42 0.29 389.66 2.52 1.95 29.23 2.18 9.61 -77.32
PBDT 275.07 145.13 89.53 649.51 419.25 54.92 571.72 510.82 11.92
Depreciation 22.02 24.33 -9.49 63.57 72.93 -12.83 97.00 119.60 -18.90
PBT 253.05 120.80 109.48 585.94 346.32 69.19 474.72 391.22 21.34
TAX 61.93 27.73 123.33 138.94 80.74 72.08 112.91 85.61 31.89
Deferred Tax 6.43 0.13 4846.15 5.84 -2.36 -347.46 -8.29 -9.95 -16.68
PAT 191.12 93.07 105.35 447.00 265.58 68.31 361.81 305.61 18.39
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 16.07 10.48 53.27 13.50 11.38 18.62 10.88 10.69 1.74
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1162.80
Cipla 1358.65
Lupin 2084.00
Zydus Lifesciences 1118.65
View more..